Joincare Pharmaceutical Group Industry Co., Ltd. Class ASSE: 600380

Announcement on Outline of the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing

· Issued by Joincare Pharmaceutical Group Industry Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Outline of the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis